B-ニコチンアミドモノヌクレオチドのグローバル市場インサイト・予測（～2028年）

• 英文タイトル：Global B-Nicotinamide Mononucleotide Market Insights and Forecast to 2028

• レポートコード：QY2203B00442 • 出版社/出版日：QYResearch / 2022年3月 • レポート形態：英文、PDF、89ページ • 納品方法：Eメール（納期：3日） • 産業分類：化学＆材料

• 販売価格（消費税別）

Single User	￥686,000 (USD4,900)	▷ お問い合わせ
Multi User	￥1,029,000 (USD7,350)	▷ お問い合わせ
Enterprise License	￥1,372,000 (USD9,800)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

新型コロナウイルス感染症のパンデミックにより、世界のB-ニコチンアミドモノヌクレオチドの市場規模は2022年にUS$xxxと推定され、調査期間中のCAGRはxxx％で、2028年までに再調整された規模はUS$xxxになると予測されています。この医療危機による経済変化を十分に考慮すると、2021年にB-ニコチンアミドモノヌクレオチドの世界市場のxxx％を占める「含有量<98％」タイプは、2028年までにUS$xxxの規模になり、パンデミック後の修正xxx％CAGRで成長すると予測されています。一方、「ヘルスケア製品」セグメントは、この予測期間を通じてxxx％のCAGRに変更されます。 中国のB-ニコチンアミドモノヌクレオチドの市場規模は2021年にUS$xxxと分析されており、米国とヨーロッパのB-ニコチンアミドモノヌクレオチド市場規模はそれぞれUS$xxxとUS$xxxです。米国の割合は2021年にxxx％であり、中国とヨーロッパはそれぞれxxx％とxxx％です。中国の割合は2028年にxxx％に達し、対象期間を通じてxxx％のCAGRを記録すると予測されています。日本、韓国、東南アジアはアジアで注目市場であり、今後6年間のCAGRはそれぞれxxx％、xxx％、xxx％になる見通しです。ヨーロッパのB-ニコチンアミドモノヌクレオチド市場については、ドイツは2028年までにUS$xxxに達すると予測されており、予測期間中のCAGRはxxx％になる見通しです。 B-ニコチンアミドモノヌクレオチドのグローバル主要メーカーには、GeneHarbor、Herbalmax、Genex Formulas、Shinkowa Pharmaceutical、Maac10 Formulas、EffePharm、Bontac、CELFULL、Kingdomwayなどがあります。2021年、世界のトップ5プレイヤーは売上ベースで約xxx％の市場シェアを占めています。 B-ニコチンアミドモノヌクレオチド市場は、種類と用途によって区分されます。世界のB-ニコチンアミドモノヌクレオチド市場のプレーヤー、利害関係者、およびその他の参加者は、当レポートを有益なリソースとして使用することで優位に立つことができます。セグメント分析は、2017年～2028年期間のタイプ別および用途別の販売量、売上、予測に焦点を当てています。 【種類別セグメント】 含有量<98％、含有量≥98％ 【用途別セグメント】 ヘルスケア製品、化粧品、その他 【掲載地域】 北米：アメリカ、カナダ ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア アジア太平洋：日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア 中南米：メキシコ、ブラジル、アルゼンチン 中東・アフリカ：トルコ、サウジアラビア、UAE 【目次（一部）】 ・調査の範囲 - B-ニコチンアミドモノヌクレオチド製品概要 - 種類別市場（含有量<98％、含有量≥98％） - 用途別市場（ヘルスケア製品、化粧品、その他） - 調査の目的 ・エグゼクティブサマリー - 世界のB-ニコチンアミドモノヌクレオチド販売量予測2017-2028 - 世界のB-ニコチンアミドモノヌクレオチド売上予測2017-2028 - B-ニコチンアミドモノヌクレオチドの地域別販売量 - B-ニコチンアミドモノヌクレオチドの地域別売上 - 北米市場 - ヨーロッパ市場 - アジア太平洋市場 - 中南米市場 - 中東・アフリカ市場 ・メーカーの競争状況 - 主要メーカー別B-ニコチンアミドモノヌクレオチド販売量 - 主要メーカー別B-ニコチンアミドモノヌクレオチド売上 - 主要メーカー別B-ニコチンアミドモノヌクレオチド価格 - 競争状況の分析 - 企業M&A動向 ・種類別市場規模（含有量<98％、含有量≥98％） - B-ニコチンアミドモノヌクレオチドの種類別販売量 - B-ニコチンアミドモノヌクレオチドの種類別売上 - B-ニコチンアミドモノヌクレオチドの種類別価格 ・用途別市場規模（ヘルスケア製品、化粧品、その他） - B-ニコチンアミドモノヌクレオチドの用途別販売量 - B-ニコチンアミドモノヌクレオチドの用途別売上 - B-ニコチンアミドモノヌクレオチドの用途別価格 ・北米市場 - 北米のB-ニコチンアミドモノヌクレオチド市場規模（種類別、用途別） - 主要国別のB-ニコチンアミドモノヌクレオチド市場規模（アメリカ、カナダ） ・ヨーロッパ市場 - ヨーロッパのB-ニコチンアミドモノヌクレオチド市場規模（種類別、用途別） - 主要国別のB-ニコチンアミドモノヌクレオチド市場規模（ドイツ、フランス、イギリス、イタリア、ロシア） ・アジア太平洋市場 - アジア太平洋のB-ニコチンアミドモノヌクレオチド市場規模（種類別、用途別） - 主要国別のB-ニコチンアミドモノヌクレオチド市場規模（日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア） ・中南米市場 - 中南米のB-ニコチンアミドモノヌクレオチド市場規模（種類別、用途別） - 主要国別のB-ニコチンアミドモノヌクレオチド市場規模（メキシコ、ブラジル、アルゼンチン） ・中東・アフリカ市場 - 中東・アフリカのB-ニコチンアミドモノヌクレオチド市場規模（種類別、用途別） - 主要国別のB-ニコチンアミドモノヌクレオチド市場規模（トルコ、サウジアラビア） ・企業情報 GeneHarbor、Herbalmax、Genex Formulas、Shinkowa Pharmaceutical、Maac10 Formulas、EffePharm、Bontac、CELFULL、Kingdomway ・産業チェーン及び販売チャネル分析 - B-ニコチンアミドモノヌクレオチドの産業チェーン分析 - B-ニコチンアミドモノヌクレオチドの原材料 - B-ニコチンアミドモノヌクレオチドの生産プロセス - B-ニコチンアミドモノヌクレオチドの販売及びマーケティング - B-ニコチンアミドモノヌクレオチドの主要顧客 ・マーケットドライバー、機会、課題、リスク要因分析 - B-ニコチンアミドモノヌクレオチドの産業動向 - B-ニコチンアミドモノヌクレオチドのマーケットドライバー - B-ニコチンアミドモノヌクレオチドの課題 - B-ニコチンアミドモノヌクレオチドの阻害要因 ・主な調査結果

Market Analysis and Insights: Global B-Nicotinamide Mononucleotide Market
Due to the COVID-19 pandemic, the global B-Nicotinamide Mononucleotide market size is estimated to be worth US$ million in 2022 and is forecast to a readjusted size of US$ million by 2028 with a CAGR of % during the review period. Fully considering the economic change by this health crisis, Content ＜98% accounting for % of the B-Nicotinamide Mononucleotide global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR in the post-COVID-19 period. While Health Care Products segment is altered to an % CAGR throughout this forecast period.
China B-Nicotinamide Mononucleotide market size is valued at US$ million in 2021, while the US and Europe B-Nicotinamide Mononucleotide are US$ million and US$ million, severally. The proportion of the US is % in 2021, while China and Europe are % and % respectively, and it is predicted that China proportion will reach % in 2028, trailing a CAGR of % through the analysis period. Japan, South Korea, and Southeast Asia are noteworthy markets in Asia, with CAGR %, %, and % respectively for the next 6-year period. As for the Europe B-Nicotinamide Mononucleotide landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period.
The global key manufacturers of B-Nicotinamide Mononucleotide include GeneHarbor, Herbalmax, Genex Formulas, Shinkowa Pharmaceutical, Maac10 Formulas, EffePharm, Bontac, CELFULL and Kingdomway. etc. In 2021, the global top five players have a share approximately % in terms of revenue.
In terms of production side, this report researches the B-Nicotinamide Mononucleotide capacity, production, growth rate, market share by manufacturers and by region (region level and country level), from 2017 to 2022, and forecast to 2028.
In terms of sales side, this report focuses on the sales of B-Nicotinamide Mononucleotide by region (region level and country level), by company, by Type and by Application. from 2017 to 2022 and forecast to 2028.
Global B-Nicotinamide Mononucleotide Scope and Segment
B-Nicotinamide Mononucleotide market is segmented by Type and by Application. Players, stakeholders, and other participants in the global B-Nicotinamide Mononucleotide market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on production capacity, revenue and forecast by Type and by Application for the period 2017-2028.
Segment by Type
Content ＜98%
Content ≥98%
Segment by Application
Health Care Products
Cosmetics
Others
By Company
GeneHarbor
Herbalmax
Genex Formulas
Shinkowa Pharmaceutical
Maac10 Formulas
EffePharm
Bontac
CELFULL
Kingdomway
Production by Region
North America
Europe
China
Japan
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE

レポート目次

---

1 Study Coverage
1.1 B-Nicotinamide Mononucleotide Product Introduction
1.2 Market by Type
1.2.1 Global B-Nicotinamide Mononucleotide Market Size by Type, 2017 VS 2021 VS 2028
1.2.2 Content ＜98%
1.2.3 Content ≥98%
1.3 Market by Application
1.3.1 Global B-Nicotinamide Mononucleotide Market Size by Application, 2017 VS 2021 VS 2028
1.3.2 Health Care Products
1.3.3 Cosmetics
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
2 Global B-Nicotinamide Mononucleotide Production
2.1 Global B-Nicotinamide Mononucleotide Production Capacity (2017-2028)
2.2 Global B-Nicotinamide Mononucleotide Production by Region: 2017 VS 2021 VS 2028
2.3 Global B-Nicotinamide Mononucleotide Production by Region
2.3.1 Global B-Nicotinamide Mononucleotide Historic Production by Region (2017-2022)
2.3.2 Global B-Nicotinamide Mononucleotide Forecasted Production by Region (2023-2028)
2.4 North America
2.5 Europe
2.6 China
2.7 Japan
3 Global B-Nicotinamide Mononucleotide Sales in Volume & Value Estimates and Forecasts
3.1 Global B-Nicotinamide Mononucleotide Sales Estimates and Forecasts 2017-2028
3.2 Global B-Nicotinamide Mononucleotide Revenue Estimates and Forecasts 2017-2028
3.3 Global B-Nicotinamide Mononucleotide Revenue by Region: 2017 VS 2021 VS 2028
3.4 Global B-Nicotinamide Mononucleotide Sales by Region
3.4.1 Global B-Nicotinamide Mononucleotide Sales by Region (2017-2022)
3.4.2 Global Sales B-Nicotinamide Mononucleotide by Region (2023-2028)
3.5 Global B-Nicotinamide Mononucleotide Revenue by Region
3.5.1 Global B-Nicotinamide Mononucleotide Revenue by Region (2017-2022)
3.5.2 Global B-Nicotinamide Mononucleotide Revenue by Region (2023-2028)
3.6 North America
3.7 Europe
3.8 Asia-Pacific
3.9 Latin America
3.10 Middle East & Africa
4 Competition by Manufactures
4.1 Global B-Nicotinamide Mononucleotide Production Capacity by Manufacturers
4.2 Global B-Nicotinamide Mononucleotide Sales by Manufacturers
4.2.1 Global B-Nicotinamide Mononucleotide Sales by Manufacturers (2017-2022)
4.2.2 Global B-Nicotinamide Mononucleotide Sales Market Share by Manufacturers (2017-2022)
4.2.3 Global Top 10 and Top 5 Largest Manufacturers of B-Nicotinamide Mononucleotide in 2021
4.3 Global B-Nicotinamide Mononucleotide Revenue by Manufacturers
4.3.1 Global B-Nicotinamide Mononucleotide Revenue by Manufacturers (2017-2022)
4.3.2 Global B-Nicotinamide Mononucleotide Revenue Market Share by Manufacturers (2017-2022)
4.3.3 Global Top 10 and Top 5 Companies by B-Nicotinamide Mononucleotide Revenue in 2021
4.4 Global B-Nicotinamide Mononucleotide Sales Price by Manufacturers
4.5 Analysis of Competitive Landscape
4.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
4.5.2 Global B-Nicotinamide Mononucleotide Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
4.5.3 Global B-Nicotinamide Mononucleotide Manufacturers Geographical Distribution
4.6 Mergers & Acquisitions, Expansion Plans
5 Market Size by Type
5.1 Global B-Nicotinamide Mononucleotide Sales by Type
5.1.1 Global B-Nicotinamide Mononucleotide Historical Sales by Type (2017-2022)
5.1.2 Global B-Nicotinamide Mononucleotide Forecasted Sales by Type (2023-2028)
5.1.3 Global B-Nicotinamide Mononucleotide Sales Market Share by Type (2017-2028)
5.2 Global B-Nicotinamide Mononucleotide Revenue by Type
5.2.1 Global B-Nicotinamide Mononucleotide Historical Revenue by Type (2017-2022)
5.2.2 Global B-Nicotinamide Mononucleotide Forecasted Revenue by Type (2023-2028)
5.2.3 Global B-Nicotinamide Mononucleotide Revenue Market Share by Type (2017-2028)
5.3 Global B-Nicotinamide Mononucleotide Price by Type
5.3.1 Global B-Nicotinamide Mononucleotide Price by Type (2017-2022)
5.3.2 Global B-Nicotinamide Mononucleotide Price Forecast by Type (2023-2028)
6 Market Size by Application
6.1 Global B-Nicotinamide Mononucleotide Sales by Application
6.1.1 Global B-Nicotinamide Mononucleotide Historical Sales by Application (2017-2022)
6.1.2 Global B-Nicotinamide Mononucleotide Forecasted Sales by Application (2023-2028)
6.1.3 Global B-Nicotinamide Mononucleotide Sales Market Share by Application (2017-2028)
6.2 Global B-Nicotinamide Mononucleotide Revenue by Application
6.2.1 Global B-Nicotinamide Mononucleotide Historical Revenue by Application (2017-2022)
6.2.2 Global B-Nicotinamide Mononucleotide Forecasted Revenue by Application (2023-2028)
6.2.3 Global B-Nicotinamide Mononucleotide Revenue Market Share by Application (2017-2028)
6.3 Global B-Nicotinamide Mononucleotide Price by Application
6.3.1 Global B-Nicotinamide Mononucleotide Price by Application (2017-2022)
6.3.2 Global B-Nicotinamide Mononucleotide Price Forecast by Application (2023-2028)
7 North America
7.1 North America B-Nicotinamide Mononucleotide Market Size by Type
7.1.1 North America B-Nicotinamide Mononucleotide Sales by Type (2017-2028)
7.1.2 North America B-Nicotinamide Mononucleotide Revenue by Type (2017-2028)
7.2 North America B-Nicotinamide Mononucleotide Market Size by Application
7.2.1 North America B-Nicotinamide Mononucleotide Sales by Application (2017-2028)
7.2.2 North America B-Nicotinamide Mononucleotide Revenue by Application (2017-2028)
7.3 North America B-Nicotinamide Mononucleotide Sales by Country
7.3.1 North America B-Nicotinamide Mononucleotide Sales by Country (2017-2028)
7.3.2 North America B-Nicotinamide Mononucleotide Revenue by Country (2017-2028)
7.3.3 U.S.
7.3.4 Canada
8 Europe
8.1 Europe B-Nicotinamide Mononucleotide Market Size by Type
8.1.1 Europe B-Nicotinamide Mononucleotide Sales by Type (2017-2028)
8.1.2 Europe B-Nicotinamide Mononucleotide Revenue by Type (2017-2028)
8.2 Europe B-Nicotinamide Mononucleotide Market Size by Application
8.2.1 Europe B-Nicotinamide Mononucleotide Sales by Application (2017-2028)
8.2.2 Europe B-Nicotinamide Mononucleotide Revenue by Application (2017-2028)
8.3 Europe B-Nicotinamide Mononucleotide Sales by Country
8.3.1 Europe B-Nicotinamide Mononucleotide Sales by Country (2017-2028)
8.3.2 Europe B-Nicotinamide Mononucleotide Revenue by Country (2017-2028)
8.3.3 Germany
8.3.4 France
8.3.5 U.K.
8.3.6 Italy
8.3.7 Russia
9 Asia Pacific
9.1 Asia Pacific B-Nicotinamide Mononucleotide Market Size by Type
9.1.1 Asia Pacific B-Nicotinamide Mononucleotide Sales by Type (2017-2028)
9.1.2 Asia Pacific B-Nicotinamide Mononucleotide Revenue by Type (2017-2028)
9.2 Asia Pacific B-Nicotinamide Mononucleotide Market Size by Application
9.2.1 Asia Pacific B-Nicotinamide Mononucleotide Sales by Application (2017-2028)
9.2.2 Asia Pacific B-Nicotinamide Mononucleotide Revenue by Application (2017-2028)
9.3 Asia Pacific B-Nicotinamide Mononucleotide Sales by Region
9.3.1 Asia Pacific B-Nicotinamide Mononucleotide Sales by Region (2017-2028)
9.3.2 Asia Pacific B-Nicotinamide Mononucleotide Revenue by Region (2017-2028)
9.3.3 China
9.3.4 Japan
9.3.5 South Korea
9.3.6 India
9.3.7 Australia
9.3.8 Taiwan
9.3.9 Indonesia
9.3.10 Thailand
9.3.11 Malaysia
9.3.12 Philippines
10 Latin America
10.1 Latin America B-Nicotinamide Mononucleotide Market Size by Type
10.1.1 Latin America B-Nicotinamide Mononucleotide Sales by Type (2017-2028)
10.1.2 Latin America B-Nicotinamide Mononucleotide Revenue by Type (2017-2028)
10.2 Latin America B-Nicotinamide Mononucleotide Market Size by Application
10.2.1 Latin America B-Nicotinamide Mononucleotide Sales by Application (2017-2028)
10.2.2 Latin America B-Nicotinamide Mononucleotide Revenue by Application (2017-2028)
10.3 Latin America B-Nicotinamide Mononucleotide Sales by Country
10.3.1 Latin America B-Nicotinamide Mononucleotide Sales by Country (2017-2028)
10.3.2 Latin America B-Nicotinamide Mononucleotide Revenue by Country (2017-2028)
10.3.3 Mexico
10.3.4 Brazil
10.3.5 Argentina
11 Middle East and Africa
11.1 Middle East and Africa B-Nicotinamide Mononucleotide Market Size by Type
11.1.1 Middle East and Africa B-Nicotinamide Mononucleotide Sales by Type (2017-2028)
11.1.2 Middle East and Africa B-Nicotinamide Mononucleotide Revenue by Type (2017-2028)
11.2 Middle East and Africa B-Nicotinamide Mononucleotide Market Size by Application
11.2.1 Middle East and Africa B-Nicotinamide Mononucleotide Sales by Application (2017-2028)
11.2.2 Middle East and Africa B-Nicotinamide Mononucleotide Revenue by Application (2017-2028)
11.3 Middle East and Africa B-Nicotinamide Mononucleotide Sales by Country
11.3.1 Middle East and Africa B-Nicotinamide Mononucleotide Sales by Country (2017-2028)
11.3.2 Middle East and Africa B-Nicotinamide Mononucleotide Revenue by Country (2017-2028)
11.3.3 Turkey
11.3.4 Saudi Arabia
11.3.5 UAE
12 Corporate Profiles
12.1 GeneHarbor
12.1.1 GeneHarbor Corporation Information
12.1.2 GeneHarbor Overview
12.1.3 GeneHarbor B-Nicotinamide Mononucleotide Sales, Price, Revenue and Gross Margin (2017-2022)
12.1.4 GeneHarbor B-Nicotinamide Mononucleotide Product Model Numbers, Pictures, Descriptions and Specifications
12.1.5 GeneHarbor Recent Developments
12.2 Herbalmax
12.2.1 Herbalmax Corporation Information
12.2.2 Herbalmax Overview
12.2.3 Herbalmax B-Nicotinamide Mononucleotide Sales, Price, Revenue and Gross Margin (2017-2022)
12.2.4 Herbalmax B-Nicotinamide Mononucleotide Product Model Numbers, Pictures, Descriptions and Specifications
12.2.5 Herbalmax Recent Developments
12.3 Genex Formulas
12.3.1 Genex Formulas Corporation Information
12.3.2 Genex Formulas Overview
12.3.3 Genex Formulas B-Nicotinamide Mononucleotide Sales, Price, Revenue and Gross Margin (2017-2022)
12.3.4 Genex Formulas B-Nicotinamide Mononucleotide Product Model Numbers, Pictures, Descriptions and Specifications
12.3.5 Genex Formulas Recent Developments
12.4 Shinkowa Pharmaceutical
12.4.1 Shinkowa Pharmaceutical Corporation Information
12.4.2 Shinkowa Pharmaceutical Overview
12.4.3 Shinkowa Pharmaceutical B-Nicotinamide Mononucleotide Sales, Price, Revenue and Gross Margin (2017-2022)
12.4.4 Shinkowa Pharmaceutical B-Nicotinamide Mononucleotide Product Model Numbers, Pictures, Descriptions and Specifications
12.4.5 Shinkowa Pharmaceutical Recent Developments
12.5 Maac10 Formulas
12.5.1 Maac10 Formulas Corporation Information
12.5.2 Maac10 Formulas Overview
12.5.3 Maac10 Formulas B-Nicotinamide Mononucleotide Sales, Price, Revenue and Gross Margin (2017-2022)
12.5.4 Maac10 Formulas B-Nicotinamide Mononucleotide Product Model Numbers, Pictures, Descriptions and Specifications
12.5.5 Maac10 Formulas Recent Developments
12.6 EffePharm
12.6.1 EffePharm Corporation Information
12.6.2 EffePharm Overview
12.6.3 EffePharm B-Nicotinamide Mononucleotide Sales, Price, Revenue and Gross Margin (2017-2022)
12.6.4 EffePharm B-Nicotinamide Mononucleotide Product Model Numbers, Pictures, Descriptions and Specifications
12.6.5 EffePharm Recent Developments
12.7 Bontac
12.7.1 Bontac Corporation Information
12.7.2 Bontac Overview
12.7.3 Bontac B-Nicotinamide Mononucleotide Sales, Price, Revenue and Gross Margin (2017-2022)
12.7.4 Bontac B-Nicotinamide Mononucleotide Product Model Numbers, Pictures, Descriptions and Specifications
12.7.5 Bontac Recent Developments
12.8 CELFULL
12.8.1 CELFULL Corporation Information
12.8.2 CELFULL Overview
12.8.3 CELFULL B-Nicotinamide Mononucleotide Sales, Price, Revenue and Gross Margin (2017-2022)
12.8.4 CELFULL B-Nicotinamide Mononucleotide Product Model Numbers, Pictures, Descriptions and Specifications
12.8.5 CELFULL Recent Developments
12.9 Kingdomway
12.9.1 Kingdomway Corporation Information
12.9.2 Kingdomway Overview
12.9.3 Kingdomway B-Nicotinamide Mononucleotide Sales, Price, Revenue and Gross Margin (2017-2022)
12.9.4 Kingdomway B-Nicotinamide Mononucleotide Product Model Numbers, Pictures, Descriptions and Specifications
12.9.5 Kingdomway Recent Developments
13 Industry Chain and Sales Channels Analysis
13.1 B-Nicotinamide Mononucleotide Industry Chain Analysis
13.2 B-Nicotinamide Mononucleotide Key Raw Materials
13.2.1 Key Raw Materials
13.2.2 Raw Materials Key Suppliers
13.3 B-Nicotinamide Mononucleotide Production Mode & Process
13.4 B-Nicotinamide Mononucleotide Sales and Marketing
13.4.1 B-Nicotinamide Mononucleotide Sales Channels
13.4.2 B-Nicotinamide Mononucleotide Distributors
13.5 B-Nicotinamide Mononucleotide Customers
14 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
14.1 B-Nicotinamide Mononucleotide Industry Trends
14.2 B-Nicotinamide Mononucleotide Market Drivers
14.3 B-Nicotinamide Mononucleotide Market Challenges
14.4 B-Nicotinamide Mononucleotide Market Restraints
15 Key Finding in The Global B-Nicotinamide Mononucleotide Study
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer

List of Tables
Table 1. Global B-Nicotinamide Mononucleotide Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 (US$ Million)
Table 2. Major Manufacturers of Content ＜98%
Table 3. Major Manufacturers of Content ≥98%
Table 4. Global B-Nicotinamide Mononucleotide Market Size Growth Rate by Application, 2017 VS 2021 2028 (US$ Million)
Table 5. Global B-Nicotinamide Mononucleotide Production by Region: 2017 VS 2021 VS 2028 (Kiloton)
Table 6. Global B-Nicotinamide Mononucleotide Production by Region (2017-2022) & (Kiloton)
Table 7. Global B-Nicotinamide Mononucleotide Production Market Share by Region (2017-2022)
Table 8. Global B-Nicotinamide Mononucleotide Production by Region (2023-2028) & (Kiloton)
Table 9. Global B-Nicotinamide Mononucleotide Production Market Share by Region (2023-2028)
Table 10. Global B-Nicotinamide Mononucleotide Revenue by Region: 2017 VS 2021 VS 2028 (US$ Million)
Table 11. Global B-Nicotinamide Mononucleotide Sales by Region (2017-2022) & (Kiloton)
Table 12. Global B-Nicotinamide Mononucleotide Sales Market Share by Region (2017-2022)
Table 13. Global B-Nicotinamide Mononucleotide Sales by Region (2023-2028) & (Kiloton)
Table 14. Global B-Nicotinamide Mononucleotide Sales Market Share by Region (2023-2028)
Table 15. Global B-Nicotinamide Mononucleotide Revenue by Region (2017-2022) & (US$ Million)
Table 16. Global B-Nicotinamide Mononucleotide Revenue Market Share by Region (2017-2022)
Table 17. Global B-Nicotinamide Mononucleotide Revenue by Region (2023-2028) & (US$ Million)
Table 18. Global B-Nicotinamide Mononucleotide Revenue Market Share by Region (2023-2028)
Table 19. Global B-Nicotinamide Mononucleotide Production Capacity by Manufacturers (2017-2022) & (Kiloton)
Table 20. Global B-Nicotinamide Mononucleotide Capacity Market Share by Manufacturers (2017-2022)
Table 21. Global B-Nicotinamide Mononucleotide Sales by Manufacturers (2017-2022) & (Kiloton)
Table 22. Global B-Nicotinamide Mononucleotide Sales Market Share by Manufacturers (2017-2022)
Table 23. Global B-Nicotinamide Mononucleotide Revenue by Manufacturers (2017-2022) & (US$ Million)
Table 24. Global B-Nicotinamide Mononucleotide Revenue Share by Manufacturers (2017-2022)
Table 25. B-Nicotinamide Mononucleotide Price by Manufacturers 2017-2022 (US$/Ton)
Table 26. Global B-Nicotinamide Mononucleotide Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 27. Global B-Nicotinamide Mononucleotide by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in B-Nicotinamide Mononucleotide as of 2021)
Table 28. B-Nicotinamide Mononucleotide Manufacturing Base Distribution and Headquarters
Table 29. Manufacturers B-Nicotinamide Mononucleotide Product Offered
Table 30. Date of Manufacturers Enter into B-Nicotinamide Mononucleotide Market
Table 31. Mergers & Acquisitions, Expansion Plans
Table 32. Global B-Nicotinamide Mononucleotide Sales by Type (2017-2022) & (Kiloton)
Table 33. Global B-Nicotinamide Mononucleotide Sales by Type (2023-2028) & (Kiloton)
Table 34. Global B-Nicotinamide Mononucleotide Sales Share by Type (2017-2022)
Table 35. Global B-Nicotinamide Mononucleotide Sales Share by Type (2023-2028)
Table 36. Global B-Nicotinamide Mononucleotide Revenue by Type (2017-2022) & (US$ Million)
Table 37. Global B-Nicotinamide Mononucleotide Revenue by Type (2023-2028) & (US$ Million)
Table 38. Global B-Nicotinamide Mononucleotide Revenue Share by Type (2017-2022)
Table 39. Global B-Nicotinamide Mononucleotide Revenue Share by Type (2023-2028)
Table 40. B-Nicotinamide Mononucleotide Price by Type (2017-2022) & (US$/Ton)
Table 41. Global B-Nicotinamide Mononucleotide Price Forecast by Type (2023-2028) & (US$/Ton)
Table 42. Global B-Nicotinamide Mononucleotide Sales by Application (2017-2022) & (Kiloton)
Table 43. Global B-Nicotinamide Mononucleotide Sales by Application (2023-2028) & (Kiloton)
Table 44. Global B-Nicotinamide Mononucleotide Sales Share by Application (2017-2022)
Table 45. Global B-Nicotinamide Mononucleotide Sales Share by Application (2023-2028)
Table 46. Global B-Nicotinamide Mononucleotide Revenue by Application (2017-2022) & (US$ Million)
Table 47. Global B-Nicotinamide Mononucleotide Revenue by Application (2023-2028) & (US$ Million)
Table 48. Global B-Nicotinamide Mononucleotide Revenue Share by Application (2017-2022)
Table 49. Global B-Nicotinamide Mononucleotide Revenue Share by Application (2023-2028)
Table 50. B-Nicotinamide Mononucleotide Price by Application (2017-2022) & (US$/Ton)
Table 51. Global B-Nicotinamide Mononucleotide Price Forecast by Application (2023-2028) & (US$/Ton)
Table 52. North America B-Nicotinamide Mononucleotide Sales by Type (2017-2022) & (Kiloton)
Table 53. North America B-Nicotinamide Mononucleotide Sales by Type (2023-2028) & (Kiloton)
Table 54. North America B-Nicotinamide Mononucleotide Revenue by Type (2017-2022) & (US$ Million)
Table 55. North America B-Nicotinamide Mononucleotide Revenue by Type (2023-2028) & (US$ Million)
Table 56. North America B-Nicotinamide Mononucleotide Sales by Application (2017-2022) & (Kiloton)
Table 57. North America B-Nicotinamide Mononucleotide Sales by Application (2023-2028) & (Kiloton)
Table 58. North America B-Nicotinamide Mononucleotide Revenue by Application (2017-2022) & (US$ Million)
Table 59. North America B-Nicotinamide Mononucleotide Revenue by Application (2023-2028) & (US$ Million)
Table 60. North America B-Nicotinamide Mononucleotide Sales by Country (2017-2022) & (Kiloton)
Table 61. North America B-Nicotinamide Mononucleotide Sales by Country (2023-2028) & (Kiloton)
Table 62. North America B-Nicotinamide Mononucleotide Revenue by Country (2017-2022) & (US$ Million)
Table 63. North America B-Nicotinamide Mononucleotide Revenue by Country (2023-2028) & (US$ Million)
Table 64. Europe B-Nicotinamide Mononucleotide Sales by Type (2017-2022) & (Kiloton)
Table 65. Europe B-Nicotinamide Mononucleotide Sales by Type (2023-2028) & (Kiloton)
Table 66. Europe B-Nicotinamide Mononucleotide Revenue by Type (2017-2022) & (US$ Million)
Table 67. Europe B-Nicotinamide Mononucleotide Revenue by Type (2023-2028) & (US$ Million)
Table 68. Europe B-Nicotinamide Mononucleotide Sales by Application (2017-2022) & (Kiloton)
Table 69. Europe B-Nicotinamide Mononucleotide Sales by Application (2023-2028) & (Kiloton)
Table 70. Europe B-Nicotinamide Mononucleotide Revenue by Application (2017-2022) & (US$ Million)
Table 71. Europe B-Nicotinamide Mononucleotide Revenue by Application (2023-2028) & (US$ Million)
Table 72. Europe B-Nicotinamide Mononucleotide Sales by Country (2017-2022) & (Kiloton)
Table 73. Europe B-Nicotinamide Mononucleotide Sales by Country (2023-2028) & (Kiloton)
Table 74. Europe B-Nicotinamide Mononucleotide Revenue by Country (2017-2022) & (US$ Million)
Table 75. Europe B-Nicotinamide Mononucleotide Revenue by Country (2023-2028) & (US$ Million)
Table 76. Asia Pacific B-Nicotinamide Mononucleotide Sales by Type (2017-2022) & (Kiloton)
Table 77. Asia Pacific B-Nicotinamide Mononucleotide Sales by Type (2023-2028) & (Kiloton)
Table 78. Asia Pacific B-Nicotinamide Mononucleotide Revenue by Type (2017-2022) & (US$ Million)
Table 79. Asia Pacific B-Nicotinamide Mononucleotide Revenue by Type (2023-2028) & (US$ Million)
Table 80. Asia Pacific B-Nicotinamide Mononucleotide Sales by Application (2017-2022) & (Kiloton)
Table 81. Asia Pacific B-Nicotinamide Mononucleotide Sales by Application (2023-2028) & (Kiloton)
Table 82. Asia Pacific B-Nicotinamide Mononucleotide Revenue by Application (2017-2022) & (US$ Million)
Table 83. Asia Pacific B-Nicotinamide Mononucleotide Revenue by Application (2023-2028) & (US$ Million)
Table 84. Asia Pacific B-Nicotinamide Mononucleotide Sales by Region (2017-2022) & (Kiloton)
Table 85. Asia Pacific B-Nicotinamide Mononucleotide Sales by Region (2023-2028) & (Kiloton)
Table 86. Asia Pacific B-Nicotinamide Mononucleotide Revenue by Region (2017-2022) & (US$ Million)
Table 87. Asia Pacific B-Nicotinamide Mononucleotide Revenue by Region (2023-2028) & (US$ Million)
Table 88. Latin America B-Nicotinamide Mononucleotide Sales by Type (2017-2022) & (Kiloton)
Table 89. Latin America B-Nicotinamide Mononucleotide Sales by Type (2023-2028) & (Kiloton)
Table 90. Latin America B-Nicotinamide Mononucleotide Revenue by Type (2017-2022) & (US$ Million)
Table 91. Latin America B-Nicotinamide Mononucleotide Revenue by Type (2023-2028) & (US$ Million)
Table 92. Latin America B-Nicotinamide Mononucleotide Sales by Application (2017-2022) & (Kiloton)
Table 93. Latin America B-Nicotinamide Mononucleotide Sales by Application (2023-2028) & (Kiloton)
Table 94. Latin America B-Nicotinamide Mononucleotide Revenue by Application (2017-2022) & (US$ Million)
Table 95. Latin America B-Nicotinamide Mononucleotide Revenue by Application (2023-2028) & (US$ Million)
Table 96. Latin America B-Nicotinamide Mononucleotide Sales by Country (2017-2022) & (Kiloton)
Table 97. Latin America B-Nicotinamide Mononucleotide Sales by Country (2023-2028) & (Kiloton)
Table 98. Latin America B-Nicotinamide Mononucleotide Revenue by Country (2017-2022) & (US$ Million)
Table 99. Latin America B-Nicotinamide Mononucleotide Revenue by Country (2023-2028) & (US$ Million)
Table 100. Middle East and Africa B-Nicotinamide Mononucleotide Sales by Type (2017-2022) & (Kiloton)
Table 101. Middle East and Africa B-Nicotinamide Mononucleotide Sales by Type (2023-2028) & (Kiloton)
Table 102. Middle East and Africa B-Nicotinamide Mononucleotide Revenue by Type (2017-2022) & (US$ Million)
Table 103. Middle East and Africa B-Nicotinamide Mononucleotide Revenue by Type (2023-2028) & (US$ Million)
Table 104. Middle East and Africa B-Nicotinamide Mononucleotide Sales by Application (2017-2022) & (Kiloton)
Table 105. Middle East and Africa B-Nicotinamide Mononucleotide Sales by Application (2023-2028) & (Kiloton)
Table 106. Middle East and Africa B-Nicotinamide Mononucleotide Revenue by Application (2017-2022) & (US$ Million)
Table 107. Middle East and Africa B-Nicotinamide Mononucleotide Revenue by Application (2023-2028) & (US$ Million)
Table 108. Middle East and Africa B-Nicotinamide Mononucleotide Sales by Country (2017-2022) & (Kiloton)
Table 109. Middle East and Africa B-Nicotinamide Mononucleotide Sales by Country (2023-2028) & (Kiloton)
Table 110. Middle East and Africa B-Nicotinamide Mononucleotide Revenue by Country (2017-2022) & (US$ Million)
Table 111. Middle East and Africa B-Nicotinamide Mononucleotide Revenue by Country (2023-2028) & (US$ Million)
Table 112. GeneHarbor Corporation Information
Table 113. GeneHarbor Description and Major Businesses
Table 114. GeneHarbor B-Nicotinamide Mononucleotide Sales (Kiloton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2017-2022)
Table 115. GeneHarbor B-Nicotinamide Mononucleotide Product Model Numbers, Pictures, Descriptions and Specifications
Table 116. GeneHarbor Recent Development
Table 117. Herbalmax Corporation Information
Table 118. Herbalmax Description and Major Businesses
Table 119. Herbalmax B-Nicotinamide Mononucleotide Sales (Kiloton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2017-2022)
Table 120. Herbalmax B-Nicotinamide Mononucleotide Product Model Numbers, Pictures, Descriptions and Specifications
Table 121. Herbalmax Recent Development
Table 122. Genex Formulas Corporation Information
Table 123. Genex Formulas Description and Major Businesses
Table 124. Genex Formulas B-Nicotinamide Mononucleotide Sales (Kiloton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2017-2022)
Table 125. Genex Formulas B-Nicotinamide Mononucleotide Product Model Numbers, Pictures, Descriptions and Specifications
Table 126. Genex Formulas Recent Development
Table 127. Shinkowa Pharmaceutical Corporation Information
Table 128. Shinkowa Pharmaceutical Description and Major Businesses
Table 129. Shinkowa Pharmaceutical B-Nicotinamide Mononucleotide Sales (Kiloton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2017-2022)
Table 130. Shinkowa Pharmaceutical B-Nicotinamide Mononucleotide Product Model Numbers, Pictures, Descriptions and Specifications
Table 131. Shinkowa Pharmaceutical Recent Development
Table 132. Maac10 Formulas Corporation Information
Table 133. Maac10 Formulas Description and Major Businesses
Table 134. Maac10 Formulas B-Nicotinamide Mononucleotide Sales (Kiloton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2017-2022)
Table 135. Maac10 Formulas B-Nicotinamide Mononucleotide Product Model Numbers, Pictures, Descriptions and Specifications
Table 136. Maac10 Formulas Recent Development
Table 137. EffePharm Corporation Information
Table 138. EffePharm Description and Major Businesses
Table 139. EffePharm B-Nicotinamide Mononucleotide Sales (Kiloton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2017-2022)
Table 140. EffePharm B-Nicotinamide Mononucleotide Product Model Numbers, Pictures, Descriptions and Specifications
Table 141. EffePharm Recent Development
Table 142. Bontac Corporation Information
Table 143. Bontac Description and Major Businesses
Table 144. Bontac B-Nicotinamide Mononucleotide Sales (Kiloton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2017-2022)
Table 145. Bontac B-Nicotinamide Mononucleotide Product Model Numbers, Pictures, Descriptions and Specifications
Table 146. Bontac Recent Development
Table 147. CELFULL Corporation Information
Table 148. CELFULL Description and Major Businesses
Table 149. CELFULL B-Nicotinamide Mononucleotide Sales (Kiloton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2017-2022)
Table 150. CELFULL B-Nicotinamide Mononucleotide Product Model Numbers, Pictures, Descriptions and Specifications
Table 151. CELFULL Recent Development
Table 152. Kingdomway Corporation Information
Table 153. Kingdomway Description and Major Businesses
Table 154. Kingdomway B-Nicotinamide Mononucleotide Sales (Kiloton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2017-2022)
Table 155. Kingdomway B-Nicotinamide Mononucleotide Product Model Numbers, Pictures, Descriptions and Specifications
Table 156. Kingdomway Recent Development
Table 157. Key Raw Materials Lists
Table 158. Raw Materials Key Suppliers Lists
Table 159. B-Nicotinamide Mononucleotide Distributors List
Table 160. B-Nicotinamide Mononucleotide Customers List
Table 161. B-Nicotinamide Mononucleotide Market Trends
Table 162. B-Nicotinamide Mononucleotide Market Drivers
Table 163. B-Nicotinamide Mononucleotide Market Challenges
Table 164. B-Nicotinamide Mononucleotide Market Restraints
Table 165. Research Programs/Design for This Report
Table 166. Key Data Information from Secondary Sources
Table 167. Key Data Information from Primary Sources
List of Figures
Figure 1. B-Nicotinamide Mononucleotide Product Picture
Figure 2. Global B-Nicotinamide Mononucleotide Market Share by Type in 2021 & 2028
Figure 3. Content ＜98% Product Picture
Figure 4. Content ≥98% Product Picture
Figure 5. Global B-Nicotinamide Mononucleotide Market Share by Application in 2021 & 2028
Figure 6. Health Care Products
Figure 7. Cosmetics
Figure 8. Others
Figure 9. B-Nicotinamide Mononucleotide Report Years Considered
Figure 10. Global B-Nicotinamide Mononucleotide Capacity, Production and Utilization (2017-2028) & (Kiloton)
Figure 11. Global B-Nicotinamide Mononucleotide Production Market Share by Region in Percentage: 2021 Versus 2028
Figure 12. Global B-Nicotinamide Mononucleotide Production Market Share by Region (2017-2022)
Figure 13. Global B-Nicotinamide Mononucleotide Production Market Share by Region (2023-2028)
Figure 14. B-Nicotinamide Mononucleotide Production Growth Rate in North America (2017-2028) & (Kiloton)
Figure 15. B-Nicotinamide Mononucleotide Production Growth Rate in Europe (2017-2028) & (Kiloton)
Figure 16. B-Nicotinamide Mononucleotide Production Growth Rate in China (2017-2028) & (Kiloton)
Figure 17. B-Nicotinamide Mononucleotide Production Growth Rate in Japan (2017-2028) & (Kiloton)
Figure 18. Global B-Nicotinamide Mononucleotide Sales 2017-2028 (Kiloton)
Figure 19. Global B-Nicotinamide Mononucleotide Revenue, (US$ Million), 2017 VS 2021 VS 2028
Figure 20. Global B-Nicotinamide Mononucleotide Revenue 2017-2028 (US$ Million)
Figure 21. Global B-Nicotinamide Mononucleotide Revenue Market Share by Region in Percentage: 2021 Versus 2028
Figure 22. Global B-Nicotinamide Mononucleotide Sales Market Share by Region (2017-2022)
Figure 23. Global B-Nicotinamide Mononucleotide Sales Market Share by Region (2023-2028)
Figure 24. North America B-Nicotinamide Mononucleotide Sales YoY (2017-2028) & (Kiloton)
Figure 25. North America B-Nicotinamide Mononucleotide Revenue YoY (2017-2028) & (US$ Million)
Figure 26. Europe B-Nicotinamide Mononucleotide Sales YoY (2017-2028) & (Kiloton)
Figure 27. Europe B-Nicotinamide Mononucleotide Revenue YoY (2017-2028) & (US$ Million)
Figure 28. Asia-Pacific B-Nicotinamide Mononucleotide Sales YoY (2017-2028) & (Kiloton)
Figure 29. Asia-Pacific B-Nicotinamide Mononucleotide Revenue YoY (2017-2028) & (US$ Million)
Figure 30. Latin America B-Nicotinamide Mononucleotide Sales YoY (2017-2028) & (Kiloton)
Figure 31. Latin America B-Nicotinamide Mononucleotide Revenue YoY (2017-2028) & (US$ Million)
Figure 32. Middle East & Africa B-Nicotinamide Mononucleotide Sales YoY (2017-2028) & (Kiloton)
Figure 33. Middle East & Africa B-Nicotinamide Mononucleotide Revenue YoY (2017-2028) & (US$ Million)
Figure 34. The B-Nicotinamide Mononucleotide Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2021
Figure 35. The Top 5 and 10 Largest Manufacturers of B-Nicotinamide Mononucleotide in the World: Market Share by B-Nicotinamide Mononucleotide Revenue in 2021
Figure 36. B-Nicotinamide Mononucleotide Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2017 VS 2021
Figure 37. Global B-Nicotinamide Mononucleotide Sales Market Share by Type (2017-2028)
Figure 38. Global B-Nicotinamide Mononucleotide Revenue Market Share by Type (2017-2028)
Figure 39. Global B-Nicotinamide Mononucleotide Sales Market Share by Application (2017-2028)
Figure 40. Global B-Nicotinamide Mononucleotide Revenue Market Share by Application (2017-2028)
Figure 41. North America B-Nicotinamide Mononucleotide Sales Market Share by Type (2017-2028)
Figure 42. North America B-Nicotinamide Mononucleotide Revenue Market Share by Type (2017-2028)
Figure 43. North America B-Nicotinamide Mononucleotide Sales Market Share by Application (2017-2028)
Figure 44. North America B-Nicotinamide Mononucleotide Revenue Market Share by Application (2017-2028)
Figure 45. North America B-Nicotinamide Mononucleotide Sales Share by Country (2017-2028)
Figure 46. North America B-Nicotinamide Mononucleotide Revenue Share by Country (2017-2028)
Figure 47. U.S. B-Nicotinamide Mononucleotide Revenue (2017-2028) & (US$ Million)
Figure 48. Canada B-Nicotinamide Mononucleotide Revenue (2017-2028) & (US$ Million)
Figure 49. Europe B-Nicotinamide Mononucleotide Sales Market Share by Type (2017-2028)
Figure 50. Europe B-Nicotinamide Mononucleotide Revenue Market Share by Type (2017-2028)
Figure 51. Europe B-Nicotinamide Mononucleotide Sales Market Share by Application (2017-2028)
Figure 52. Europe B-Nicotinamide Mononucleotide Revenue Market Share by Application (2017-2028)
Figure 53. Europe B-Nicotinamide Mononucleotide Sales Share by Country (2017-2028)
Figure 54. Europe B-Nicotinamide Mononucleotide Revenue Share by Country (2017-2028)
Figure 55. Germany B-Nicotinamide Mononucleotide Revenue (2017-2028) & (US$ Million)
Figure 56. France B-Nicotinamide Mononucleotide Revenue (2017-2028) & (US$ Million)
Figure 57. U.K. B-Nicotinamide Mononucleotide Revenue (2017-2028) & (US$ Million)
Figure 58. Italy B-Nicotinamide Mononucleotide Revenue (2017-2028) & (US$ Million)
Figure 59. Russia B-Nicotinamide Mononucleotide Revenue (2017-2028) & (US$ Million)
Figure 60. Asia Pacific B-Nicotinamide Mononucleotide Sales Market Share by Type (2017-2028)
Figure 61. Asia Pacific B-Nicotinamide Mononucleotide Revenue Market Share by Type (2017-2028)
Figure 62. Asia Pacific B-Nicotinamide Mononucleotide Sales Market Share by Application (2017-2028)
Figure 63. Asia Pacific B-Nicotinamide Mononucleotide Revenue Market Share by Application (2017-2028)
Figure 64. Asia Pacific B-Nicotinamide Mononucleotide Sales Share by Region (2017-2028)
Figure 65. Asia Pacific B-Nicotinamide Mononucleotide Revenue Share by Region (2017-2028)
Figure 66. China B-Nicotinamide Mononucleotide Revenue (2017-2028) & (US$ Million)
Figure 67. Japan B-Nicotinamide Mononucleotide Revenue (2017-2028) & (US$ Million)
Figure 68. South Korea B-Nicotinamide Mononucleotide Revenue (2017-2028) & (US$ Million)
Figure 69. India B-Nicotinamide Mononucleotide Revenue (2017-2028) & (US$ Million)
Figure 70. Australia B-Nicotinamide Mononucleotide Revenue (2017-2028) & (US$ Million)
Figure 71. Taiwan B-Nicotinamide Mononucleotide Revenue (2017-2028) & (US$ Million)
Figure 72. Indonesia B-Nicotinamide Mononucleotide Revenue (2017-2028) & (US$ Million)
Figure 73. Thailand B-Nicotinamide Mononucleotide Revenue (2017-2028) & (US$ Million)
Figure 74. Malaysia B-Nicotinamide Mononucleotide Revenue (2017-2028) & (US$ Million)
Figure 75. Philippines B-Nicotinamide Mononucleotide Revenue (2017-2028) & (US$ Million)
Figure 76. Latin America B-Nicotinamide Mononucleotide Sales Market Share by Type (2017-2028)
Figure 77. Latin America B-Nicotinamide Mononucleotide Revenue Market Share by Type (2017-2028)
Figure 78. Latin America B-Nicotinamide Mononucleotide Sales Market Share by Application (2017-2028)
Figure 79. Latin America B-Nicotinamide Mononucleotide Revenue Market Share by Application (2017-2028)
Figure 80. Latin America B-Nicotinamide Mononucleotide Sales Share by Country (2017-2028)
Figure 81. Latin America B-Nicotinamide Mononucleotide Revenue Share by Country (2017-2028)
Figure 82. Mexico B-Nicotinamide Mononucleotide Revenue (2017-2028) & (US$ Million)
Figure 83. Brazil B-Nicotinamide Mononucleotide Revenue (2017-2028) & (US$ Million)
Figure 84. Argentina B-Nicotinamide Mononucleotide Revenue (2017-2028) & (US$ Million)
Figure 85. Middle East and Africa B-Nicotinamide Mononucleotide Sales Market Share by Type (2017-2028)
Figure 86. Middle East and Africa B-Nicotinamide Mononucleotide Revenue Market Share by Type (2017-2028)
Figure 87. Middle East and Africa B-Nicotinamide Mononucleotide Sales Market Share by Application (2017-2028)
Figure 88. Middle East and Africa B-Nicotinamide Mononucleotide Revenue Market Share by Application (2017-2028)
Figure 89. Middle East and Africa B-Nicotinamide Mononucleotide Sales Share by Country (2017-2028)
Figure 90. Middle East and Africa B-Nicotinamide Mononucleotide Revenue Share by Country (2017-2028)
Figure 91. Turkey B-Nicotinamide Mononucleotide Revenue (2017-2028) & (US$ Million)
Figure 92. Saudi Arabia B-Nicotinamide Mononucleotide Revenue (2017-2028) & (US$ Million)
Figure 93. UAE B-Nicotinamide Mononucleotide Revenue (2017-2028) & (US$ Million)
Figure 94. B-Nicotinamide Mononucleotide Value Chain
Figure 95. B-Nicotinamide Mononucleotide Production Process
Figure 96. Channels of Distribution
Figure 97. Distributors Profiles
Figure 98. Bottom-up and Top-down Approaches for This Report
Figure 99. Data Triangulation
Figure 100. Key Executives Interviewed

---